1.

Record Nr.

UNINA9910452566103321

Titolo

Vaccines for the prevention of cervical cancer [[electronic resource] /] / edited by Peter L. Stern and Henry C. Kitchener

Pubbl/distr/stampa

Oxford, : Oxford University Press, 2008

ISBN

0-19-174006-3

0-19-960718-4

1-283-58126-4

9786613893710

0-19-157545-3

Descrizione fisica

1 online resource (170 p.)

Collana

Oxford oncology library

Altri autori (Persone)

SternPeter L

KitchenerHenry C

Disciplina

616.99/466

Soggetti

Cervix uteri - Cancer - Prevention

Cancer vaccines

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Contents; Preface; Contributors; Abbreviations; Glossary; Part 1-Prevention and current treatment; 1 The UK cervical screening programme; 2 Management of cervical intraepithelial neoplasia (CIN); Part 2-HPV and disease; 3 Role of HPV in cervical carcinogenesis; 4 HPV and genital cancer: the essential epidemiology; 5 The role of HPV testing in cervical screening; Part 3-Immune control of HPV infection in cervical neoplasia; 6 Natural immune control of HPV infection; 7 Prophylactic HPV vaccines: pre-clinical and proof of principle studies; 8 Prophylactic HPV vaccination: current status

9 Introduction of HPV prophylactic vaccination Part 4-Challenges and future developments; 10 HPV vaccination in the developing world; 11 Screening post vaccination; 12 Second-generation HPV prophylactic vaccines; 13 Therapeutic HPV vaccines; 14 Conclusion; Index;

Sommario/riassunto

Cervical cancer is the second most common form of cancer found in women and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now



known to be caused by two types of the human papilloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and how cervical cancer screening will change following vaccination.Part of the Oxford Oncology Library series, this practice